Clinical Trials

NCT04550494 | ACTIVE_NOT_RECRUITING | PHASE2
29 participants

Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2021-04-26
Completion:
2026-07-10
Conditions
  • Anatomic Stage III Breast Cancer AJCC v8
  • Anatomic Stage IV Breast Cancer AJCC v8
  • Castration-Resistant Prostate Carcinoma
  • Clinical Stage III Gastric Cancer AJCC v8
  • Clinical Stage IV Gastric Cancer AJCC v8
  • HER2-Positive Breast Carcinoma
  • Locally Advanced Breast Carcinoma
  • Locally Advanced Gastric Carcinoma
  • Locally Advanced Malignant Solid Neoplasm
  • Locally Advanced Ovarian Carcinoma
  • Locally Advanced Pancreatic Carcinoma
  • Locally Advanced Prostate Carcinoma
  • Metastatic Breast Carcinoma
  • Metastatic Gastric Carcinoma
  • Metastatic Malignant Solid Neoplasm
  • Metastatic Ovarian Carcinoma
  • Metastatic Pancreatic Carcinoma
  • Metastatic Prostate Carcinoma
  • Platinum-Sensitive Ovarian Carcinoma
  • Recurrent Breast Carcinoma
  • Recurrent Gastric Carcinoma
  • Recurrent Ovarian Carcinoma
  • Recurrent Pancreatic Carcinoma
  • Recurrent Prostate Carcinoma
  • Stage II Pancreatic Cancer AJCC v8
  • Stage III Ovarian Cancer AJCC v8
  • Stage III Pancreatic Cancer AJCC v8
  • Stage III Prostate Cancer AJCC v8
  • Stage IV Ovarian Cancer AJCC v8
  • Stage IV Pancreatic Cancer AJCC v8
  • Stage IV Prostate Cancer AJCC v8
Interventions
  • PROCEDURE
  • DRUG
No Results Yet
NCT04526782 | ACTIVE_NOT_RECRUITING | PHASE2
119 participants

ENCOrafenib With Binimetinib in bRAF NSCLC

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2021-01-19
Completion:
2025-07-16
Conditions
  • Non Small Cell Lung Cancer
  • BRAF V600E
Interventions
  • DRUG
No Results Yet
NCT04236349 | COMPLETED
30 participants

Tuberculosis Cohort in the North of Paris

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-11
Start Date:
2018-05-01
Completion:
2021-02-17
Conditions
  • Pulmonary Tuberculosis
  • Extra Pulmonary Tuberculosis
Interventions
  • GENETIC
No Results Yet
NCT04222413 | RECRUITING | PHASE1
116 participants

Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2020-10-27
Completion:
2027-12-31
Conditions
  • Advanced Solid Tumors
  • Metastatic Pancreatic Cancer
  • Pediatric Solid Tumor
  • Advanced Breast Cancer
  • Malignant Peripheral Nerve Sheath Tumor
  • Colorectal Neoplasms
Interventions
  • DRUG
No Results Yet
NCT04208529 | ENROLLING_BY_INVITATION | PHASE3
160 participants

A Long-term Follow-up Study in Participants Who Received CTX001

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2021-01-20
Completion:
2039-09-30
Conditions
  • Beta-Thalassemia
  • Thalassemia
  • Sickle Cell Disease
  • Hematologic Diseases
  • Hemoglobinopathies
  • Genetic Diseases, Inborn
  • Sickle Cell Anemia
Interventions
  • BIOLOGICAL
No Results Yet
NCT04164082 | ACTIVE_NOT_RECRUITING | PHASE2
161 participants

Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2020-03-18
Completion:
2026-12-09
Conditions
  • Bladder Flat Urothelial Carcinoma In Situ
  • Non-Muscle Invasive Bladder Urothelial Carcinoma
  • Stage 0a Bladder Cancer AJCC v8
  • Stage 0is Bladder Cancer AJCC v8
  • Stage I Bladder Cancer AJCC v8
Interventions
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
No Results Yet
NCT04092283 | ACTIVE_NOT_RECRUITING | PHASE3
660 participants

Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2020-04-29
Completion:
2028-12-31
Conditions
  • Recurrent Lung Non-Small Cell Carcinoma
  • Stage III Lung Cancer AJCC v8
  • Stage IIIA Lung Cancer AJCC v8
  • Stage IIIB Lung Cancer AJCC v8
  • Stage IIIC Lung Cancer AJCC v8
  • Unresectable Lung Non-Small Cell Carcinoma
Interventions
  • DRUG
  • BIOLOGICAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page